Sihuan Pharmaceutical Holdings GroupSHPHF 52 Dividend Yield % is 1.08% as of Jun. 25, 2026, which is 46% below its 10-year median of 2.01. GuruFocus rates SHPHF with a GF Score™ of 52/100 and a GF Value™ of $0.17 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 516 Drug Manufacturers companies, Sihuan Pharmaceutical Holdings Group ranks worse than 63.18% on this metric.
SHPHF'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.44 Med: 2.01 Max: 7.25
Current: 1.08
During the past 13 years, the highest Dividend Yield of Sihuan Pharmaceutical Holdings Group was 7.25%. The lowest was 0.44%. And the median was 2.01%.
SHPHF's Dividend Yield % is ranked worse than 63.18% of 516
companies
in the Drug Manufacturers industry
Industry Median: 2.005
vs SHPHF: 1.08
During the past 13 years, the highest Dividend Payout Ratio of Sihuan Pharmaceutical Holdings Group was 0.65. The lowest was 0.11. And the median was 0.35.
During the past 12 months, Sihuan Pharmaceutical Holdings Group's average Dividends Per Share Growth Rate was -45.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -11.70% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was -1.00% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was -10.80% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Sihuan Pharmaceutical Holdings Group was 35.70% per year. The lowest was -37.00% per year. And the median was -3.75% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Sihuan Pharmaceutical Holdings Group (OTCPK:SHPHF) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sihuan Pharmaceutical Holdings Group Dividend Yield % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Sihuan Pharmaceutical Holdings Group's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sihuan Pharmaceutical Holdings Group Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sihuan Pharmaceutical Holdings Group's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Sihuan Pharmaceutical Holdings Group's Dividend Yield % falls into.
Sihuan Pharmaceutical Holdings Group Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Sihuan Pharmaceutical Holdings Group Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
HKD 0.010900
2025-09-26
2025-09-30
2025-10-10
Cash Dividend
semi-annually
HKD:USD 0.128520
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sihuan Pharmaceutical Holdings Group (SHPHF) has a Dividend Yield % of 1.08% as of Jun. 25, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Sihuan Pharmaceutical Holdings Group and its competitors. This is 46% below median its historical median of 2.01. Over the past decade, Sihuan Pharmaceutical Holdings Group's Dividend Yield % has ranged from 0.44 to 7.25. According to the industry distribution chart, Sihuan Pharmaceutical Holdings Group ranks #326 out of 516 companies in the Drug Manufacturers industry, placing it in the top 63.2%.
Is Sihuan Pharmaceutical Holdings Group's Dividend Yield % too high?
Sihuan Pharmaceutical Holdings Group's current Dividend Yield % of 1.08% is 46% below median its 10-year median of 2.01. Over the past 10 years, this metric has ranged from a low of 0.44 to a high of 7.25. The Drug Manufacturers industry median Dividend Yield % is 2.01. Sihuan Pharmaceutical Holdings Group's value of 1.08% is 46.1% below this industry median. Based on the distribution chart, Sihuan Pharmaceutical Holdings Group ranks #326 out of 516 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Sihuan Pharmaceutical Holdings Group has a GF Score™ of 52/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sihuan Pharmaceutical Holdings Group's Dividend Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sihuan Pharmaceutical Holdings Group ranks #326 out of 516 companies for Dividend Yield %. This places Sihuan Pharmaceutical Holdings Group in the lower half of its industry. The industry median Dividend Yield % is 2.01. Sihuan Pharmaceutical Holdings Group's value of 1.08% is 46.1% below this benchmark. Historically, Sihuan Pharmaceutical Holdings Group's own Dividend Yield % has ranged from 0.44 to 7.25 over the past decade. While the company's 10-year median is 2.01 vs. the industry median of 2.01, Sihuan Pharmaceutical Holdings Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 2.01, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sihuan Pharmaceutical Holdings Group's current Dividend Yield % of 1.08% is 46.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Sihuan Pharmaceutical Holdings Group and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 2.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sihuan Pharmaceutical Holdings Group's current Dividend Yield % is 1.08%, which is 46% below median its own 10-year median of 2.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sihuan Pharmaceutical Holdings Group stock overvalued right now?
Based on GuruFocus' analysis, Sihuan Pharmaceutical Holdings Group (SHPHF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.17, compared to a current price of $0.13 — trading 23.7% below its estimated fair value. The current Dividend Yield % is 1.08%, which is 46% below median its 10-year median of 2.01 and 46.1% below the Drug Manufacturers industry median of 2.01. Sihuan Pharmaceutical Holdings Group's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Sihuan Pharmaceutical Holdings Group (SHPHF), the current Dividend Yield % is 1.08% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sihuan Pharmaceutical Holdings Group (SHPHF) Overvalued in 2026?
Based on GuruFocus' analysis, Sihuan Pharmaceutical Holdings Group stock appears to be undervalued.
The current stock price of $0.13 is trading 23.7% below its estimated GF Value™ of $0.17.
GuruFocus considers Sihuan Pharmaceutical Holdings Group to be Modestly Undervalued.
Key valuation signals for SHPHF:
Dividend Yield %: 1.08% (46% below median its 10-year median of 2.01)
GF Value™: $0.17 vs. price of $0.13 (23.7% below fair value)
Industry Position: 46.1% below the Drug Manufacturers median (#326 of 516)
No single metric tells the full story. See the SHPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sihuan Pharmaceutical Holdings Group Business Description
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment, including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the innovative medicine and other medicine segment; and the generic medicine segment, which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.
52GF Score
Get the complete analysis for SHPHF
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHPHF has been successfully added to your 
